A. Ugur Ural and F. Avcu, “Additive/synergistic anti-tumoral effects of the combination of docetaxel and zoledronic acid on prostate cancer cells: Possible mechanisms?”, AO, vol. 45, no. 4, pp. 491–492, Jan. 2006.